Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigation of a set of flavonoid compounds as Helicobacter pylori urease inhibitors: insights from in silico studies

28 Dec 2023

Abstract excerpt

Helicobacter pylori (H. pylori) is a spiral, microaerophilic gram-negative bacterium, which is associated with the destruction of the lining of the stomach, leads to chronic inflammation of the stomach, which can cause stomach and duodenal ulcers. The problems caused by the treatment with antibiotics have caused researchers to use new approaches to treat infections caused by H. pylori, among them specific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Helicobacter pylori-related gastroenterology studies
Share to Synthesis and biological activity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38153379
DOI: 10.1080/07391102.2023.2295973

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigation of a set of flavonoid compounds as Helicobacter pylori urease inhibitors: insights from in silico studiesPMID 38153379Read ↗

In Silico exploration for potent phytochemicals targeting Helicobacter pylori: assessment of ADMET profiles and molecular docking analysisSemantic proximity Read ↗

Mechanistic inhibition of gastric cancer-associated bacteria Helicobacter pylori by selected phytocompounds: A new cutting-edge computational approachSemantic proximity Read ↗

Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeuticsSemantic proximity Read ↗

In vitro anti-Helicobacter pylori activity and phenotypic screening of novel quinolone compounds.Semantic proximity Read ↗

Identification of novel drug targets in HpB38, HpP12, HpG27, Hpshi470, HpSJM180 strains of Helicobacter pylori : an in silico approach for therapeutic intervention.Semantic proximity Read ↗

Repurposing FDA-Approved Agents to Develop a Prototype Helicobacter Pylori Shikimate Kinase (HPSK) inhibitor: A Computational Approach Using Virtual Screening, MM-GBSA Calculation, MD Simulations, and DFT AnalysisSemantic proximity Read ↗

In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pyloriSemantic proximity Read ↗

High-throughput screening and molecular dynamics simulations of natural products targeting LuxS/AI-2 system as a novel antibacterial strategy for antibiotic resistance in Helicobacter pyloriSemantic proximity Read ↗

Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrASemantic proximity Read ↗

Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approachSemantic proximity Read ↗

Identification of novel drug targets for Helicobacter pylori: structure-based virtual screening of potential inhibitors against DAH7PS protein involved in the shikimate pathwaySemantic proximity Read ↗

Epigallocatechin Gallate with Potent Anti-Helicobacter pylori Activity Binds Efficiently to Its Histone-like DNA Binding ProteinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.